Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (371-380 of 463) with videos related to

Pageof 47
Sort By:
Inflammatory Bowel Diseases|October 24, 2019
Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's DiseaseJames D Lewis, Paul Rutgeerts, Brian G Feagan, et al.
Contemporary Clinical Trials Communications|July 4, 2020
A dietary intervention to improve the microbiome composition of pregnant women with Crohn's disease and their offspring: The MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial designInga Peter, Ana Maldonado-Contreras, Caroline Eisele, et al.
Journal of Crohn'S & Colitis|January 13, 2025
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studiesRemo Panaccione, Edouard Louis, Jean-Frederic Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 4, 2024
Anti-integrin αvβ6 Autoantibodies are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease SeverityHannah Bloemen, Alexandra E Livanos, Adrielly Martins, et al.
Gut|June 5, 2025
Adherent-invasive <i>Escherichia coli</i> in Crohn's disease: the 25th anniversaryNicolas Barnich, Janelle C Arthur, Anthony Buisson, et al.
The New England Journal of Medicine|May 24, 2023
Upadacitinib Induction and Maintenance Therapy for Crohn's DiseaseEdward V Loftus, Julian Panés, Ana P Lacerda, et al.
Journal of Crohn'S & Colitis|August 31, 2023
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label ExtensionSilvio Danese, Remo Panaccione, Maria T Abreu, et al.
Inflammatory Bowel Diseases|March 11, 2019
Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel DiseaseRobert P Hirten, Ari Grinspan, Shih-Chen Fu, et al.
Gastroenterology|August 20, 2013
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONICMarc Ferrante, Jean-Frederic Colombel, William J Sandborn, et al.
Journal of Crohn'S & Colitis|November 24, 2020
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD RegistryManasi Agrawal, Erica J Brenner, Xian Zhang, et al.
Pageof 47

Showing results (371-380 of 463) with videos related to

Sort By:
Pageof 47
Inflammatory Bowel Diseases|October 24, 2019
Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's DiseaseJames D Lewis, Paul Rutgeerts, Brian G Feagan, et al.
Contemporary Clinical Trials Communications|July 4, 2020
A dietary intervention to improve the microbiome composition of pregnant women with Crohn's disease and their offspring: The MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial designInga Peter, Ana Maldonado-Contreras, Caroline Eisele, et al.
Journal of Crohn'S & Colitis|January 13, 2025
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studiesRemo Panaccione, Edouard Louis, Jean-Frederic Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 4, 2024
Anti-integrin αvβ6 Autoantibodies are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease SeverityHannah Bloemen, Alexandra E Livanos, Adrielly Martins, et al.
Gut|June 5, 2025
Adherent-invasive <i>Escherichia coli</i> in Crohn's disease: the 25th anniversaryNicolas Barnich, Janelle C Arthur, Anthony Buisson, et al.
The New England Journal of Medicine|May 24, 2023
Upadacitinib Induction and Maintenance Therapy for Crohn's DiseaseEdward V Loftus, Julian Panés, Ana P Lacerda, et al.
Journal of Crohn'S & Colitis|August 31, 2023
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label ExtensionSilvio Danese, Remo Panaccione, Maria T Abreu, et al.
Inflammatory Bowel Diseases|March 11, 2019
Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel DiseaseRobert P Hirten, Ari Grinspan, Shih-Chen Fu, et al.
Gastroenterology|August 20, 2013
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONICMarc Ferrante, Jean-Frederic Colombel, William J Sandborn, et al.
Journal of Crohn'S & Colitis|November 24, 2020
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD RegistryManasi Agrawal, Erica J Brenner, Xian Zhang, et al.
Pageof 47